5 Key Takeaways

• 1

  Premium IOLs were projected to account for just under 17% of global units in 2025, while toric lenses represented only 6% to 8% of cataract procedures.

• 2

  An estimated 52% to 70% of cataract patients have astigmatism sufficient to qualify for toric lenses, and only about 13% of eligible US patients have had laser refractive surgery.

• 3

  The article argues that patient adoption may be limited by barriers in the care journey, including cost, concerns about nighttime vision, practice confidence, and awareness.

• 4

  In the 2015 ASCRS Clinical Survey, cost was the leading barrier to presbyopia-correcting IOL adoption, followed by concern about nighttime quality of vision.

• 5

  The proposed approach is to identify the largest patient-journey bottleneck, improve its use of existing resources, align other activities with it, add capacity if needed, and repeat.